Furthermore, preclinical studies investigating the therapeutic potential of NGF/BDNF in neurodegenerative diseases have demonstrated that NGF/BDNF cross-regulates Notch signaling pathways, indicating that complex interplay between these signaling networks is involved in disease pathogenesis and potential treatment outcomes [76]. This evidence concerns the gene NGF and neurodegenerative disease.